Glythera Limited Company Profile

09:18 EDT 25th May 2018 | BioPortfolio

News Articles [45 Associated News Articles listed on BioPortfolio]

Avacta and Glythera agree partnership, following positive trial results

Avacta Group has announced a licensing deal with UK biotech firm Glythera and that its initial study…

Glythera appoints Chief Scientific Officer and strengthens SAB

Dr Robert Lutz appointed as CSO to support development of next-generation PermaLink® Antibody Drug Conjugates Dr Jon Roffey appointed to Scientific Advisory Board Newcastle, UK, 17t...

Glythera inks alternative antibody deal with Avacta

Glythera has signed a licensing deal to develop drug conjugates using Avactaâs Affimer technology.

Glythera appoints Professor Kerry Chester to SAB - Appointment supports the development of the Company’s pipeline

Newcastle, UK, 30th April, 2018: Glythera Limited (Glythera), the next-generation antibody drug conjugate (ADC) development company, today announces that it has appointed Professor Kerry Chester ...

Avacta signs licensing deal with Glythera after successful trial

Avacta Group has signed a licensing agreement with Glythera for its Affimer technology after a successful proof-of-concept study.

Avacta agrees licensing deal with antibody drug conjugates specialist Glythera

"I am delighted with the reciprocal arrangements that we have put in place with Glythera allowing both companies to develop Affimer-Permalink drug conjugates," said Avacta's CEO, Alastair Smith

Avacta partners with Glythera to advance drug conjugates

Avacta and Glythera agreed to work together to develop drug conjugates using their combined technologies.  -More- 

Avacta, Glythera link to develop drug conjugates

UK companies Avacta and Glythera have sealed a licensing deal to develop drug conjugates using their combined technologies.

PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [84 Associated Companies listed on BioPortfolio]


Glythera Limited

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...


More Information about "Glythera Limited" on BioPortfolio

We have published hundreds of Glythera Limited news stories on BioPortfolio along with dozens of Glythera Limited Clinical Trials and PubMed Articles about Glythera Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Glythera Limited Companies in our database. You can also find out about relevant Glythera Limited Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record